Midazolam (Nasus Pharma)

咪达唑仑 (Nasus Pharma)

Report date: 2024/03/08 17:56:31

Base Information

Drug NameMidazolam (Nasus Pharma)
Drug Alias NameNS-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSeizures
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNasus Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNasus Pharma
Inactive CompaniesN/A
Active IndicationsSeizures
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A